Resistance to methotrexate in SKOV-3 cell lines after chronic exposure to carbamazepine is associated with a decreased expression of folate receptor

International Journal of Cancer

Volumn 85, Issue 5, 2000, Pages 683-690

  Toffoli, Giuseppe ^a   Corona, Giuseppe ^a   Tolusso, Barbara ^a   Sartor, Franca ^a   Sorio, Roberto ^a   Mini, Enrico ^b   Boiocchi, Mauro ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

10 PROPARGYL 5,8 DIDEAZAFOLIC ACID; CARBAMAZEPINE; CISPLATIN; DOXORUBICIN; FLOXURIDINE; MESSENGER RNA; METHOTREXATE; PACLITAXEL; RALTITREXED; RECEPTOR; VINCRISTINE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER RESISTANCE; CELL GROWTH; CONCENTRATION (PARAMETERS); CROSS RESISTANCE; CYTOTOXICITY; HUMAN; HUMAN CELL; OVARY CANCER; PRIORITY JOURNAL;

BIOLOGICAL TRANSPORT; CARBAMAZEPINE; CARRIER PROTEINS; CELL DIVISION; CELL SURVIVAL; CISPLATIN; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; METHOTREXATE; OVARIAN NEOPLASMS; PACLITAXEL; RECEPTORS, CELL SURFACE; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; VINCRISTINE;

EID: 0033952717     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(20000301)85:5<683::AID-IJC14>3.0.CO;2-U     Document Type: Article

References (28)

1. BERTINO, J.R., Ode to methotrexate. J. clin. Oncol., 11, 5-14 (1993).
2. CHUNG, K., SAIKAWA, Y., PAIK, T., DIXON, K.H., MULLIGAN, T., COWAN, K.H. and ELWOOD, P.C., Stable transfectans of human MCF-7 breast cancer cells with increased levels of the human folate receptor exhibit an increased sensitivity to antifolates. J. clin. Invest., 91, 1289-1294 (1993).
3. CORONA, G., GIANNINI, F., FABRIS, M., TOFFOLI, G. and BOIOCCHI, M., Role of folate receptor and reduced folate carrier in the transport of 5-methyl-tetrahydrofolic acid in human ovarian carcinoma cells. Int. J. Cancer, 75, 125-133 (1998).
4. COWAN, K.H., GOLDSMITH, M.E., LEVINE, R.M., AITKEN, S.C., DOUGLLASS, E., CLENDENINN, N., NIENHUIS, A.W. and LIPPMAN, M.E., Dihydrofolate reductase gene amplification and possible rearrangement in estrogen-responsive methotrexate-resistant human breast cancer cells. J. biol. Chem., 257, 15079-15086 (1982).
5. FINNELL, R.H., WLODARCZYK, B.C., CRAIG, J.C., PIEDRAHITA, J.A. and BENNETT, G.D., Strain-dependent alterations in the expression of folate pathway genes following teratogenic exposure to valproic acid in a mouse model. Amer. J. Med. Genet., 70, 303-311 (1997).
6. HENDERSON, G.B. and STRAUSS, B.P., Characteristics of a novel transport system for folate compounds in wild-type and methotrexate-resistant 11210 cells. Cancer Res., 50, 1709-1714 (1990).
7. JANSEN, G., Receptor-and carrier-mediated transport systems for folates and antifolates. In: A.N. Jackman (ed.), Receptor-and carrier-mediated transport systems for folates and antifolates, Human Press, Totowa, NJ (1999).
8. JANSEN, G., MAURITZ, R.M., ASSARAF, Y.G., SPRECHER, H., DRORI, S., KATHMANN, I., WESTERHOF, G.R., PRIEST, D.G., BUNNI, M., PINEDO, H.M., SCHORNAGEL, J.H. and PETERS, G.J., Regulation of carrier-mediated transport of folates and antifolates in methotrexate-sensitive and -resistant leukemia cells. Adv. Enzyme Regul., 37, 59-76 (1997).
9. JANSEN, G., SCHORNAGEL, J.H., KATHMANN, I., WESTERHOF, G.R., HORDUK, G. and VAN DER LAAN, B.F.A.M., Measurement of folylpolyglutamate synthetase activity in head and neck squamous carcinoma cell lines and clinical samples using a new rapid separation procedure. Oncol. Res., 4, 299-306 (1992).
10. JANSEN, G., WESTERHOF, G.R., KATHMANN. I., RADEMAKER, B.C., RIJKSEN, G. and SCHORNAGEL, J.H., Identification of a membrane-associated folate-binding protein in human leukemic Cerf-Cem cells with transport-related methotrexate resistance. Cancer Res., 49, 2455-2459 (1989).
11. JOEL, S.P., SHAH, R., CLARK, P.I. and SLEVIN, M.L., Predicting etoposide toxicity: relationship to organ function and protein binding. J. clin. Oncol., 1, 257-267 (1996).
12. KIM, J.S., LOWE, K.E. and SHANE, B., Regulation of folate and one-carbon metabolism in mammalian cells. iv. Role of folylpoly-gamma-glutamate synthetase in methotrexate metabolism and cytotoxicity. J. biol. Chem., 268, 21680-21685 (1993).
13. KISHI, T., FUJITA, N., EGUCHI, T. and UEDA, K., Mechanism for reduction of serum folate by antiepileptic drugs during prolonged therapy. J. neurol. Sci., 145, 109-112 (1997).
14. KUTZBACH, C. and STOKSTAD, E.L.R., Feedback inhibition of methylene-tetrahydrofolate reductase in rat liver by S-adenosylmethionine. Biochim. biophys. Acta, 139, 217-220 (1967).
15. LEWIS, D.P., VAN DYKE, D.C., STUMBO, P.J. and BERG, M.J., Drug and environmental factors associated with adverse pregnancy outcomes. Part II: Improvement with folic acid. Ann. Pharmacother., 32, 947-961 (1998).
16. LUCOCK, M.D., WILD, J., SCHORAH, C.J., LEVENE, M.I. and HARTLEY, R., The methylfolate axis in neural tube defects: in vitro characterisation and clinical investigation. Biochem. Med. Metab. Biol., 52, 101-114 (1994).
17. MACDONALD, R.L. and KELLY, K.M., Antiepileptic drug mechanisms of action. Epilepsia, 36, S2-12 (1995).
18. MIOTTI, S., FACHERIS, P., TOMASSETTI, A., BOTTERO, F., BOTTINI, C., OTTONE, F., COLNAGHI, M.I., BUNNI, M.A., PRIEST, D.G. and CANEVARI, S., Growth of ovarian-carcinoma cell lines at physiological folate concentration: effect on folate-binding protein expression in vitro and in vivo. Int. J. Cancer, 63, 395-401 (1995).
19. MOSCOW, J.A., Methotrexate transport and resistance. Leukemia Lymphoma, 30, 215-224 (1998).
20. ROBERTS, D., An isotopic assay for thymidylate synthetase. Biochemistry, 5, 3546-3548 (1966).
21. ROY, K., TOLNER, B., CHIAO, J.H. and SIROTNAK, F.M., A single amino acid difference within the folate transporter encoded by the murine RFC-1 gene selectively alters its interaction with folate analogues. Implications for intrinsic antifolate resistance and directional orientation of the transporter within the plasma membrane of tumor cells. J. biol. Chem., 273, 2526-2531 (1998).
22. SPINELLA, M.J., BRIGLE, K.E., FREEMANTLE, S.J., SIERRA, E.E. and GOLDMAN, I.D., Comparison of methotrexate polyglutamylation in 11210 leukemia cells when influx is mediated by the reduced folate carrier or the folate receptor: lack of evidence for influx route-specific effects. Proc. Ann. Meet. Amer. Assoc. Cancer Res., 37, A2607 (1996).
23. STANDER, M., DICHGANS, J. and WELLER, M., Anticonvulsant drugs fail to modulate chemotherapy-induced cytotoxicity and growth inhibition of human malignant glioma cells. J. Neuro-Oncol., 3, 191-198 (1998).
24. TOFFOLI, G., SIMONE, F., GIGANTE, M. and BOIOCCHI, M., Comparison of mechanisms responsible for resistance to idarubicin and daunorubicin in multidrug resistant lovo cell lines. Biochem. Pharmacol., 48, 1871-1881 (1994).
25. TSE, A., BRIGLE, K., TAYLOR, S.M. and MORAN, R.G., Mutations in the reduced folate carrier gene which confer dominant resistance to 5,10-dideazaletrahydrofolate. J. biol. Chem., 273, 25953-25960 (1998).
26. WANG, X., SHEN, F., FREISHEIM, J.H., GENTRY, L.E. and RATNAM, M., Differential stereospecificities and affinities of folate receptor isoforms for folate compounds and antifolates. Biochem. Pharmacol., 44,1898-1901 (1992).
27. WESTERHOF, G.R., RIJNBOUTT, S., SCHORNAGEL, J.H., PINEDO, H.M., PETERS, G.J. and JANSEN, G., Functional activity of the reduced folate carrier in KB, MA104, and IGROV-1 cells expressing folate-binding protein. Cancer Res., 17, 3795-3802 (1995a).
28. WESTERHOF, G.R., SCHORNAGEL, J.H., KATHMANN, I., JACKMAN, A.L., ROSOWSKY, A., FORSCH, R.A., HYNES, J.B., BOYLE, F.T., PETERS, G.J., PINEDO, H.M. and JANSEN, G., Carrier-and receptor-mediated transport of folate antagonists targeting folate-dependent enzymes: correlates of molecular-structure and biological activity. Mol. Pharmacol., 48, 459-471 (1995b).